Omeros Corporation
OMER
#6174
Rank
โ‚น90.02 B
Marketcap
โ‚น1,250
Share price
7.18%
Change (1 day)
119.16%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.33 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น14.7 Billion a decrease over its 2023 earnings that were of -โ‚น13.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.33 Billion-29.76%
2024 -โ‚น14.7 Billion9.63%
2023 -โ‚น13.41 Billion-9.57%
2022 -โ‚น14.83 Billion-30.65%
2021 -โ‚น21.38 Billion86.28%
2020 -โ‚น11.48 Billion99.45%
2019 -โ‚น5.76 Billion-49.91%
2018 -โ‚น11.49 Billion190.77%
2017 -โ‚น3.95 Billion-27.96%
2016 -โ‚น5.49 Billion-17.61%
2015 -โ‚น6.66 Billion1.88%
2014 -โ‚น6.54 Billion87.56%
2013 -โ‚น3.49 Billion
2011 -โ‚น2.56 Billion-8.96%
2010 -โ‚น2.81 Billion45.03%
2009 -โ‚น1.94 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.121 T-28,167.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น948.26 B-8,625.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.36 Billion-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-โ‚น0.89 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA